ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY
ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY
批准号:
6484674
负责人:
Mark J Mamula
金额:
$24.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2002-09-29
关键词:
B lymphocyte T cell receptor T lymphocyte antibody formation antigen presenting cell autoantibody autoantigens autoimmunity cell migration experimental allergic encephalomyelitis immune tolerance /unresponsiveness immunoregulation laboratory mouse leukocyte activation /transformation myelin basic proteins passive immunization peptides posttranslational modifications proteolipids small nuclear ribonucleoproteins systemic lupus erythematosus tissue /cell culture
中文摘要
系统性自身免疫性疾病是多种因素复杂相互作用的产物
英文摘要
Systematic autoimmune disease are the product of a complex interaction of
lymphocytes, soluble macromolecules, and self tissues leading to the
pathology of disease. Autoimmune responses often target multiple
determinants within an autoantigen in a phenomenon known as epitope
spreading. For example, in systemic lupus erythematosus (SLE),
autoantibodies are direct at a number of determinants on small nuclear
ribonucleoproteins (snRNPs) and on nucleosomes. In the murine model of
human multiple sclerosis, experimental autoimmune encephalomyelitis (EAE),
disease that is induced with a single self peptide of myelin basic protein
soon diversities to multiple sites on the protein during the course of
disease. The concept of epitope spreading is a fundamentally important
mechanism of the immune system that enhances the ability to clear vital or
bacterial infection or to resist tumor challenges. For example, the most
efficient means by which to clear an infectious agent is to direct an
immune attack against as they sites on the target as possible. One
objective of this proposal is to examine the role of B lymphocytes, as
autoantigen presenting cells, in the spreading of autoimmunity. Are B
cells specific for a short self peptides able to present diverse
autoantigenic determinants in eliciting a diverse T cell autoimmune
response?
The types of self antigens presented in the context of MHC molecules are
critical in many aspects of immune responses, from positive and negative
selection in the thymus to the activation of autoimmune T cells in the
periphery. We have recently identified a novel post translational protein
modification that confers immunogenicity to otherwise immunologically
inert self peptides. The second objective of this proposal will examine
the expression of these post translational modifications in lymphocytes
and the role od modified peptides in the autoimmunity of SLE and EAE.
Overall, our studies will address mechanisms important in the induction
and perpetuation of autoimmune disease. A more thorough understanding of
the earlier events in the genesis of autoimmune disease may help identify
important elements to exploit for the immunologic intervention of these
diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
-
批准号:9909591
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2019
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8647974
-
项目类别:
-
资助金额:$26.29万
-
财政年份:2013
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7673607
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7680476
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:7330500
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8150350
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7352535
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7352530
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8000852
-
项目类别:
-
资助金额:$62.87万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:6742316
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7288356
-
项目类别:
-
资助金额:$57.48万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7158302
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Isoaspartyl Modified Tumor Antigens for Vaccination
-
批准号:6840749
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6337076
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6511529
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6877090
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:7464321
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:8240037
-
项目类别:
-
资助金额:$40.55万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:8971933
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6632440
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
海外基金